首页 | 本学科首页   官方微博 | 高级检索  
检索        

氯吡格雷对急性冠脉综合征患者血清sCD_(40)L的影响
引用本文:刘满江,闫世林.氯吡格雷对急性冠脉综合征患者血清sCD_(40)L的影响[J].基层医学论坛,2008,12(28):873-874.
作者姓名:刘满江  闫世林
作者单位:杨凌示范区医院,陕西,杨凌,712100
摘    要:目的通过测定ACS患者血清sCD40L水平的变化,探讨氯吡格雷治疗对ACS患者PCI前后血清sCD40L水平的影响,及施行PCI术本身对患者血清sCD40L水平的影响。方法80例诊断为急性冠脉综合征的患者,采用双抗夹心酶联免疫吸附法测定未服氯吡格雷前、服用氯吡格雷后PCI术前、术后第1天、术后第5天的血清sCD40L水平。所有患者均接受规范的抗缺血治疗。结果急性冠脉综合征患者未服氯吡格雷前血清sCD40L水平为(17.47±2.69)ng/ml,显著高于服用氯吡格雷后PCI术前(13.83±2.69)ng/m(lP<0.05)。术后第1天(19.05±3.05)ng/ml显著高于服用氯吡格雷后PCI术前(13.83±2.69)ng/m(lP<0.05)。术后第5天(9.45±2.37)ng/ml显著低于术后第1天(19.05±3.05)ng/m(lP<0.05)。结论早期服用氯吡格雷可显著降低急性冠脉综合征患者血清sCD40L水平。

关 键 词:急性冠脉综合征  经皮冠状动脉介入治疗  可溶性CD_(40)配体  氯吡格雷  酶联免疫吸附测定  粥样斑块

Effect of clopidogrel on serum sCD40L level in patients with acute coronary syndromes
Liu Manjang,Yan Shilin.Effect of clopidogrel on serum sCD40L level in patients with acute coronary syndromes[J].Public Medical Forum Magazine,2008,12(28):873-874.
Authors:Liu Manjang  Yan Shilin
Institution:Liu Manjang,Yan Shilin.Department of cardiology,Yang ling distict hospital,Shan xi 712100
Abstract:Objective To observe the effect of treatment with clopidogrel on serum soluble CD40 ligant level in patients with acute coronary syndromes(ACS) before and after PCI,and understand the effect of treatment with clopidogrel on serum soluble CD40 ligant level in patients with acute coronary syndromes before and after PCI,and the effect of PCI it self on serum soluble CD40L.Methods 80 cases initially diagnosed as acute coronary syndromes(ACS),Serum sCD40L level were determined by enzyme linked immunosorbent assa...
Keywords:Acute coronary syndromes Percutaneous coronary intervention Soluble CD_(40) ligant Clopidogrel Enzyme linked immunosorbent assay Atherosclerosis
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号